Core structure of gp41 from the HIV envelope glycoprotein

Cell

Volumn 89, Issue 2, 1997, Pages 263-273

  Chan, David C ^a,b   Fass, Deborah ^a,b   Berger, James M ^a   Kim, Peter S ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; VIRUS ENVELOPE PROTEIN; VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; ONCOVIRINAE;

EID: 0030970693     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80205-6     Document Type: Article

References (76)

1. Allan, J.S., Allan, J.S., Strauss, J., and Buck, D.W. (1990). Enhancement of SIV infection with soluble receptor molecules. Science 247, 1084-1088.
2. Blacklow, S.C., Lu, M., and Kim, P.S. (1995). A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry 34, 14955-14962.
3. Broder, C.C., and Dimitrov, D.S. (1996). HIV and the 7-transmembrane domain receptors. Pathobiology 64, 171-179.
4. Brünger, A.T. (1992a). A system for X-ray crystallography and NMR. X-PLOR Version 3.1. (New Haven, Connecticut: Yale University Press).
5. Brünger, A.T. (1992b). Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-475.
6. Bullough, P.A., Hughson, F.M., Skehel, J.J., and Wiley, D.C. (1994). Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371, 37-43.
7. Cao, J., Bergeron, L., Helseth, E., Thali, M., Repke, H., and Sodroski, J. (1993). Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67, 2747-2755.
8. Carr, C.M., and Kim, P.S. (1993). A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73, 823-832.
9. (1994). Collaborative computational project, Number 4. Acta Cryst. D50, 760-763.
10. Chambers, P., Pringle, C.R., and Easton, A.J. (1990). Heptad repeat regions are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71, 3075-3080.
11. Chen, C.H., Matthews, T.J., McDanal, C.B., Bolognesi, D.P., and Greenberg, M.L. (1995a). A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determinesthe anti-HIV activity of gp41 derivatives: implication for viral fusion. J. Virol. 69, 3771-3777.
12. 2) folds in Escherichia coli into the low-pH-induced conformation. Proc. Natl. Acad. Sci. USA 92, 12205-12209.
13. Chen, S.S. (1994). Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 60, 2002-2010.
14. Chen, S.S., Lee, C.N., Lee, W.R., McIntosh, K., and Lee, T.H. (1993). Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J. Virol. 67, 3615-3619.
15. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D., Wu, L., Mackay, C.R., LaRosa, G., Newman, W., Gerard, N., Gerard, C., and Sodroski, J. (1996). The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
16. Cohen, C., and Parry, D.A. (1990). Alpha-helical coiled coils and bundles: how to design an alpha-helical protein. Proteins 7, 1-15.
17. Cohen, J. (1996). Investigators detail HIV's fatal handshake. Science 274, 502.
18. Cowtan, K.D. (1994). Joint CCP4 and ESF-EACBM. Newslett. Prot. Crystallogr. 31, 34-38.
19. Crick, F.H.C. (1953). The packing of α-helices: simple coiled coils. Acta Cryst. 6, 689-697.
20. D'Souza, M.P., and Harden, V.A. (1996). Chemokines and HIV-1 second receptors. Nature Med. 2, 1293-1300.
21. Daar, E.S., Li, X.L., Moudgil, T., Ho, D.D. (1990). High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA 87, 6574-6578.
22. Delwart, E.L., Moialos, G., and Gilmore, T. (1990). Retroviral envelope glycoproteins contain a leucine zipper-like repeat. AIDS Res. Hum. Retroviruses 6, 703-706.
23. Dubay, J.W., Roberts, S.J., Brody, B., and Hunter, E. (1992). Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66, 4748-4756.
24. Edelhoch, H. (1967). Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6, 1948-1954.
25. Fass, D., and Kim, P.S. (1995). Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr. Biol. 5, 1377-1383.
26. Fass, D., Harrison, S.C., and Kim, P.S. (1996). Structure of Moloney murine virus envelope domain at 1.7Å resolution. Nature Struct. Biol. 3, 465-469.
27. Freed, E.O., and Martin, M.A. (1995). The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 270, 23883-23886.
28. Gallaher, W.R., Ball, J.M., Garry, R.F., Griffin, M.C., and Montelaro, R.C. (1989). A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 5, 431-440.
29. Harbury, P.B., Zhang, T., Kim, P.S., and Alber, T. (1993). A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science 262, 1401-1407.
30. Harbury, P., Kim, P.S., and Alber, T. (1994). Crystal structure of an isoleucine-zipper trimer. Nature 371, 80-83.
31. Hart, T.K., Kirsch, R., Ellens, H., Sweet, R.W., Lambert, D.M., Petteway, S.R., Jr., Learly, J., and Bugelski, P.J. (1991). Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 88, 2189-2193.
32. Helseth, E., Olshevsky, U., Furman, U., and Sodroski, J. (1991). Human immunodeficiency virus type 1 glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 65, 2119-2123.
33. Hendrickson, W.A. (1991). Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. Science 254, 51-58.
34. Herskowitz, I. (1987). Functional inactivation of genes by dominant negative mutations. Nature 329, 219-222.
35. Hunter, E., and Swanstrom, R. (1990). Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157, 187-253.
36. Jiang, S., Lin, K., Strick, N., and Neurath, A.R. (1993). HIV-1 inhibition by a peptide. Nature 365, 113.
37. Jones, T.A., and Kjeldgaard, M. (1992). O - The Manual (Uppsala, Sweden: http://kaktus.kemi.aau.dk).
38. Kalyanaraman, V.S., Rodriguez, V., Veronese, F., Rahman, R., Lusso, P., DeVico, A.L., Copeland, T., Oroszlan, S., Gallo, R.C., and Sarngadharan, M.G. (1990). Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 6, 371-380.
39. Kraulis, P. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 924-950.
40. Lambert, D.M., Barney, S., Lambert, A.L., Guthrie, K., Medinas, R., Davis, D.E., Bucy, T., Erickson, J., Merutka, G., and Petteway, S.R., Jr. (1996). Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93, 2186-2191.
41. Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291.
42. Lawless, M., Barney, S., Guthrie, K.I., Bucy, T.B., Petteway, S.R., Jr., and Merutka, G. (1996). HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry 35, 13697-13708.
43. Lipsky, J.J. (1996). Antiretroviral drugs for AIDS. Lancet 348, 800-803.
44. Lu, M., Blacklow, S.C., and Kim, P.S. (1995). A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Struct. Biol. 2, 1075-1082.
45. Luciw, P.A. (1996). Human immunodeficiency viruses and their replication. In Fields Virology, Third Edition, B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman, and S.E. Straus, eds. (Philadelphia: Lippincott-Raven Publishers), pp. 1881-1952.
46. Moore, J.P., McKeating, J.A., Weiss, R.A., and Sattentau, Q.J. (1990). Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250, 1139-1142.
47. Moore, J.P., Cao, Y., Qing, L., Sattentau, Q.J., Pyati, J., Koduri, R., Robinson, J., Barbas, C.F., III, Burton, D.R., and Ho, D.D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69, 101-109.
48. Nara, P.L., Robey, W.G., Pyle, S.W., Hatch, W.C., Dunlop, N.M., Bess, J.W., Jr., Kelliher, J.C., Arthur, L.O., and Fischinger, P.J. (1988). Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies. J. Virol. 62, 2622-2628.
49. Nicholls, A., Sharp, K.A., and Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
50. Oas, T.G., and Kim, P.S. (1988). A peptide model of a protein folding intermediate. Nature 336, 42-48.
51. O'Shea, E.K., Klemm, J.D., Kim, P.S., and Alber, T. (1991). X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254, 539-544.
52. Otwinoski, Z. (1991). Maximum likelihood refinement of heavy atom parameters. In Isomorphous Replacement and Anomalous Scattering. W. Wolf, P.R. Evans, and A.G.W. Leslie, eds. (Warrington, England: SERC, Daresbury Laboratory) pp. 80-86.
53. Otwinoski, Z. (1993). Oscillation data reduction program. In Data Collection and Processing. L. Sawyer, N. Isaacs, S. Bailey, eds. (Warrington, England: SERC, Daresbury Laboratory) pp. 56-62.
54. Palker, T.J., Clark, M.E., Langlois, A.J., Matthews, T.J., Weinhold, K.J., Randall, R.R., Bolognesi, D.P., and Haynes, B.F. (1988). Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85, 1932-1936.
55. Poumbourios, P., Wilson, K.A., Center, R.J., El Ahmar, W., and Kemp, B.E. (1997). Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/ leucine zipper-like sequence. J. Virol. 71, 2041-2049.
56. Rabenstein, M.D., and Shin, Y.K. (1996). HIV-1 gp41 tertiary structure studied by EPR spectroscopy. Biochemistry 35, 13922-13928.
57. Rabenstein, M., and Shin, Y.K. (1995). A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry 34, 13390-13397.
58. Sattentau, Q.J., and Moore, J.P. (1991). Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174, 407-415.
59. Sattentau, Q.J., and Moore, J.P. (1993). The role of CD4 in HIV binding and entry. Phil. Trans. Royal Soc. B 342, 59-66.
60. Sattentau, Q.J., Moore, J.P., Vignaux, F., Traincard, F., and Poignard, P. (1993). Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67, 7383-7393.
61. Shugars, D.C., Wild, C.T., Greenwell, T.K., and Matthews, T.J. (1996). Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 70, 2982-2991.
62. Stamatatos, L., and Cheng-Mayer, C. (1995). Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. J. Virol. 69, 6191-6198.
63. Stegmann, T., Delfino, J.M., Richards, F.M., and Helenius, A. (1991). The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. J. Biol. Chem. 266, 18404-18410.
64. Stegmann, T., and Helenius, A. (1993). Influenza virus fusion: from models toward a mechanism. In Viral Fusion Mechanisms, J. Bentz, ed. (Boca Raton, Florida: CRC Press), pp. 89-111.
65. Sullivan, N., Sun, Y., Li, J., Hofmann, W., and Sodroski, J. (1995). Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69, 4413-4422.
66. Trkola, A., Dragic, T., Arthos, J., Binley, J.M., Olson, W.C., Allaway, G.P., Cheng-Mayer, C., Robinson, J., Maddon, P.J., and Moore, J.P. (1996). CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184-187.
67. 2 NH2-terminal segment during influenza virus-induced membrane fusion. J. Biol. Chem. 267, 20225-20232.
68. White, J.M. (1992). Membrane fusion. Science 258, 917-924.
69. Wild, C.T., Oas, T., McDanal, C.B., Bolognesi, D., and Matthews, T.J. (1992). A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89, 10537-10541.
70. Wild, C., Dubay, J.W., Greenwell, T., Baird, T., Jr., Oas, T.G., McDanal, C., Hunter, E., and Matthews, T. (1994a). Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA 91, 12676-12680.
71. Wild, C.T., Shugars, D.C., Greenwell, T.K., McDanal, C.B., and Matthews, T.J. (1994b). Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91, 9770-9774.
72. Wild, C., Greenwell, T., Shugars, D., Rimsky-Clarke, L., and Matthews, T. (1995). The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Retroviruses 11, 323-325.
73. Wiley, D.C., and Skehel, J.J. (1987). The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56, 365-394.
74. Wilkinson, D. (1996). HIV-1: cofactors provide the entry keys. Curr. Biol. 6, 1051-1053.
75. Wilson, I.A., Skehel, J.J., and Wiley, D.C. (1981). Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289, 366-373.
76. Wu, L., Gerard, N.P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsett, A., Cardoso, A.A., Desjardin, E., Newman, W., Gerard, C., and Sodroski, J. (1996). CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179-183.